{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T09:04:55Z","timestamp":1780995895244,"version":"3.54.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,9]]},"DOI":"10.7759\/cureus.110511","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:44:09Z","timestamp":1780994649000},"source":"Crossref","is-referenced-by-count":0,"title":["Limited Access to Blinatumomab in Morocco: Challenges and Implications"],"prefix":"10.7759","author":[{"given":"Nabiha","family":"El Abdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"El Ouafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Azzahra","family":"Lahlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouama","family":"Bouanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609783","article-title":"Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia","volume":"376","author":"Kantarjian H","year":"2017","unstructured":"Kantarjian H, Stein A, G\u00f6kbuget N, et al.. Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. N Engl J Med. 2017, 376:836-47. 10.1056\/NEJMoa1609783","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-798322","article-title":"Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia","volume":"131","author":"G\u00f6kbuget N","year":"2018","unstructured":"G\u00f6kbuget N, Dombret H, Bonifacio M, et al.. Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia. Blood. 2018, 131:1522-31. 10.1182\/blood-2017-08-798322","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2205-5","article-title":"Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years","volume":"16","author":"Elidrissi Errahhali M","year":"2016","unstructured":"Elidrissi Errahhali M, Elidrissi Errahhali M, Boulouiz R, Ouarzane M, Bellaoui M. Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years. BMC Cancer. 2016, 16:159. 10.1186\/s12885-016-2205-5","journal-title":"BMC Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2013.16.31.2791","article-title":"Cancer incidence in Morocco: report from Casablanca registry 2005-2007","volume":"16","author":"Bouchbika Z","year":"2013","unstructured":"Bouchbika Z, Haddad H, Benchakroun N, et al.. Cancer incidence in Morocco: report from Casablanca registry 2005-2007. Pan Afr Med J. 2013, 16:31. 10.11604\/pamj.2013.16.31.2791","journal-title":"Pan Afr Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-024-02262-9","article-title":"Investigating the availability, affordability, and market dynamics of innovative oncology drugs in Morocco: an original report","volume":"23","author":"Benhima N","year":"2024","unstructured":"Benhima N, Afani L, Fadli ME, Ess\u00e2di I, Belbaraka R. Investigating the availability, affordability, and market dynamics of innovative oncology drugs in Morocco: an original report. Int J Equity Health. 2024, 23:217. 10.1186\/s12939-024-02262-9","journal-title":"Int J Equity Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/GO-25-00469","article-title":"Optimizing blinatumomab access for low- and middle-income countries: feasibility of a shortened, vial-sharing, outpatient approach for pediatric ALL","volume":"12","author":"Colunga Pedraza JE","year":"2026","unstructured":"Colunga Pedraza JE, G\u00f3mez-De Le\u00f3n A, Colunga Pedraza PR, et al.. Optimizing blinatumomab access for low- and middle-income countries: feasibility of a shortened, vial-sharing, outpatient approach for pediatric ALL. JCO Glob Oncol. 2026, 12:e2500469. 10.1200\/GO-25-00469","journal-title":"JCO Glob Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s43058-022-00310-5","article-title":"Evaluating blinatumomab implementation in low- and middle-income countries: a study protocol","volume":"3","author":"Duffy C","year":"2022","unstructured":"Duffy C, Santana V, Inaba H, et al.. Evaluating blinatumomab implementation in low- and middle-income countries: a study protocol. Implement Sci Commun. 2022, 3:62. 10.1186\/s43058-022-00310-5","journal-title":"Implement Sci Commun"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30549","article-title":"Improving access to high-cost cancer drugs in Latin America: much to be done","volume":"123","author":"Ruiz R","year":"2017","unstructured":"Ruiz R, Strasser-Weippl K, Touya D, et al.. Improving access to high-cost cancer drugs in Latin America: much to be done. Cancer. 2017, 123:1313-23. 10.1002\/cncr.30549","journal-title":"Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485039-limited-access-to-blinatumomab-in-morocco-challenges-and-implications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:44:13Z","timestamp":1780994653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485039-limited-access-to-blinatumomab-in-morocco-challenges-and-implications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.110511","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,9]]}}}